Fig. 2From: Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatmentProgression free survival of patients with T4 N0/1 M0 non-small cell lung cancer treated with definitive ccRTx/CTx (RCTx 1) in comparison to patients of the same TNM stage who underwent a trimodality treatment (trimodal 2) (p = 0.276, Log rank test)Back to article page